This paper examines modern serum proteomics approaches and their application in precision medicine, with a focus on disease stratification and the development of predictive, proactive treatment strategies in dermatology.
No specific quantitative outcomes are reported in the available metadata; the paper appears to be a review or perspective on the use of serum proteomics for patient stratification and treatment optimization.
Full text is unavailable; summary is based solely on the title and metadata, which limits the ability to extract specific findings, study populations, or quantitative results.
Serum proteomics may offer clinicians new tools to stratify patients and guide proactive, personalized treatment decisions in dermatologic disease — though specific clinical recommendations require review of the full paper.
Explore related topics
